MMED

News

prnewswire.comMiniMed's Smallest App-Controlled Insulin Pump is Now Available in the U.S.prnewswire.comJun 17

marketbeat.comMiniMed Group Q4 Earnings Call Highlightsmarketbeat.comJun 3

prnewswire.comMiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbottprnewswire.comJun 3

prnewswire.comMiniMed Delivers Strong Fourth Quarter and Full Fiscal Year 2026 Financial Results; Provides Fiscal Year 2027 Outlookprnewswire.comJun 3

prnewswire.comMiniMed to Showcase MiniMed Flex™ and MiniMed Go™ at the American Diabetes Association Scientific Sessionsprnewswire.comMay 27

Trade MMED

About MiniMed Group, Inc. Common Stock

MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.

CEO: Que Thanh Dallara
IPO Date: Mar 5, 2026

Market Data

Open: $14.39
High: $14.96
Low: $14.17
Volume: 2.1M
Avg Volume: 822.3K
52W High: $20.48
52W Low: $10.65

Valuation

Market Cap: $4.1B
Enterprise Value: $4.1B
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-53M
Revenue: $2.7B
Net Income: $-250M
Cash: $11M
Debt: $11M

Events

EarningsSep 30

EPS est. 0.1098